MEDEXPETS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDEXPETS
Largest movements
- Receivables within one year +€5,505
up €5,505 (+38.1%), from €14,446 to €19,951
of which Other amounts receivable: +€11,660
- Profit (loss) carried forward +€17,508
up €17,508 (+23.6%), from €74,197 to €91,706
- Tax, wage and social debts -€13,037
down €13,037 (-63.0%), from €20,709 to €7,672
- Gross operating margin -€32,371
down €32,371 (-53.8%), from €60,128 to €27,757
- Taxes -€8,084
down €8,084 (-55.2%), from €14,656 to €6,572
- Financial charges +€1,181
up €1,181 (+59.2%), from €1,994 to €3,175
- Financial income +€623
up €623 (+333.6%), from €187 to €810
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €98,052 | €101,664 | +€3,612 | +3.7% |
| Fixed assets | 21/28 | €3,197 | €2,453 | -€744 | -23.3% |
| Tangible fixed assets | 22/27 | €3,197 | €2,453 | -€744 | -23.3% |
| Plant, machinery and equipment | 23 | €1,881 | €1,438 | -€443 | -23.6% |
| Furniture and vehicles | 24 | €1,316 | €1,015 | -€301 | -22.9% |
| Current assets | 29/58 | €94,854 | €99,211 | +€4,357 | +4.6% |
| Amounts receivable within one year | 40/41 | €14,446 | €19,951 | +€5,505 | +38.1% |
| Trade receivables | 40 | €9,170 | €3,015 | -€6,155 | -67.1% |
| Other amounts receivable | 41 | €5,276 | €16,936 | +€11,660 | +221.0% |
| Cash at bank and in hand | 54/58 | €80,083 | €79,260 | -€823 | -1.0% |
| Deferred charges and accrued income | 490/1 | €326 | €0 | -€326 | -100.0% |
| Total equity and liabilities | 10/49 | €98,052 | €101,664 | +€3,612 | +3.7% |
| Equity | 10/15 | €75,197 | €92,706 | +€17,508 | +23.3% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €74,197 | €91,706 | +€17,508 | +23.6% |
| Amounts payable | 17/49 | €22,854 | €8,958 | -€13,896 | -60.8% |
| Amounts payable within one year | 42/48 | €22,854 | €8,958 | -€13,896 | -60.8% |
| Trade debts | 44 | €2,145 | €1,286 | -€859 | -40.1% |
| Suppliers | 440/4 | €2,145 | €1,286 | -€859 | -40.1% |
| Taxes, remuneration and social security | 45 | €20,709 | €7,672 | -€13,037 | -63.0% |
| Taxes | 450/3 | €20,709 | €7,672 | -€13,037 | -63.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €525 | €744 | +€219 | +41.8% |
| Other operating charges | 640/8 | €564 | €567 | +€3 | +0.5% |
| Gross operating margin | 9900 | €60,128 | €27,757 | -€32,371 | -53.8% |
| Operating profit (loss) | 9901 | €59,038 | €26,445 | -€32,593 | -55.2% |
| Financial income | 75/76B | €187 | €810 | +€623 | +333.6% |
| Recurring financial income | 75 | €187 | €810 | +€623 | +333.6% |
| Financial charges | 65/66B | €1,994 | €3,175 | +€1,181 | +59.2% |
| Recurring financial charges | 65 | €1,994 | €3,175 | +€1,181 | +59.2% |
| Profit (loss) for the period before taxes | 9903 | €57,232 | €24,080 | -€33,151 | -57.9% |
| Income taxes | 67/77 | €14,656 | €6,572 | -€8,084 | -55.2% |
| Profit (loss) for the period | 9904 | €42,575 | €17,508 | -€25,067 | -58.9% |
| Profit (loss) for the period to be appropriated | 9905 | €42,575 | €17,508 | -€25,067 | -58.9% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.